Imunon, Inc. Increase (Decrease) in Deferred Revenue
Imunon, Inc. (IMNN) reported Increase (Decrease) in Deferred Revenue of -$500.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2023-03-30
- Imunon, Inc. increase (decrease) in deferred revenue for the quarter ending 2018-09-30 was -$125.00K.
- Imunon, Inc. increase (decrease) in deferred revenue for the quarter ending 2018-06-30 was -$125.00K.
- Imunon, Inc. increase (decrease) in deferred revenue for the quarter ending 2018-03-31 was -$125.00K.
- Imunon, Inc. increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was -$125.00K.
- Imunon, Inc. increase (decrease) in deferred revenue for fiscal 2022 was -$500.00K.
- Imunon, Inc. increase (decrease) in deferred revenue for fiscal 2021 was -$500.00K.
- Imunon, Inc. increase (decrease) in deferred revenue for fiscal 2020 was -$500.00K.
- Imunon, Inc. increase (decrease) in deferred revenue for fiscal 2017 was -$500.00K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 3 month as first filed | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|---|
| 2022-12-31 | -$500.00K 10-K · filed 2023-03-30 | ||||
| 2021-12-31 | -$500.00K 10-K · filed 2023-03-30 | ||||
| 2020-12-31 | -$500.00K 10-K · filed 2022-03-31 | ||||
| 2018-09-30 | -$125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$250.00K derived: sum of 2 quarters · filed 2018-11-14 | -$375.00K 10-Q · filed 2018-11-14 | -$500.00K derived: sum of 4 quarters · filed 2018-11-14 | |
| 2018-06-30 | -$125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$250.00K 10-Q · filed 2018-08-14 | -$375.00K derived: sum of 3 quarters · filed 2018-08-14 | -$500.00K derived: sum of 4 quarters · filed 2018-11-14 | |
| 2018-03-31 | -$125.00K 10-Q · filed 2018-05-11 | -$250.00K derived: sum of 2 quarters · filed 2018-05-11 | -$375.00K derived: sum of 3 quarters · filed 2018-11-14 | -$500.00K derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-12-31 | -$125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-27 | -$250.00K derived: sum of 2 quarters · filed 2018-11-14 | -$375.00K derived: sum of 3 quarters · filed 2018-11-14 | -$500.00K 10-K · filed 2018-03-27 | |
| 2017-09-30 | -$125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$250.00K derived: sum of 2 quarters · filed 2018-11-14 | -$375.00K 10-Q · filed 2018-11-14 | -$500.00K derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-06-30 | -$125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$250.00K 10-Q · filed 2018-08-14 | -$375.00K derived: sum of 3 quarters · filed 2018-08-14 | -$500.00K derived: sum of 4 quarters · filed 2018-08-14 | |
| 2017-03-31 | -$125.00K 10-Q · filed 2018-05-11 | -$250.00K derived: sum of 2 quarters · filed 2018-05-11 | -$375.00K derived: sum of 3 quarters · filed 2018-05-11 | -$500.00K derived: sum of 4 quarters · filed 2018-05-11 | |
| 2016-12-31 | -$125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-27 | -$250.00K derived: sum of 2 quarters · filed 2018-03-27 | -$375.00K derived: sum of 3 quarters · filed 2018-03-27 | -$500.00K 10-K · filed 2018-03-27 | |
| 2016-09-30 | -$125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$250.00K derived: sum of 2 quarters · filed 2017-11-14 | -$375.00K 10-Q · filed 2017-11-14 | -$500.00K derived: sum of 4 quarters · filed 2017-11-14 | |
| 2016-06-30 | -$125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$250.00K 10-Q · filed 2017-08-14 | -$375.00K derived: sum of 3 quarters · filed 2017-08-14 | -$500.00K derived: sum of 4 quarters · filed 2017-08-14 | |
| 2016-03-31 | -$125.00K 10-Q · filed 2017-05-12 | -$250.00K derived: sum of 2 quarters · filed 2017-05-12 | -$375.00K derived: sum of 3 quarters · filed 2017-05-12 | -$500.00K derived: sum of 4 quarters · filed 2017-05-12 | |
| 2015-12-31 | -$125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24 | -$250.00K derived: sum of 2 quarters · filed 2017-03-24 | -$375.00K derived: sum of 3 quarters · filed 2017-03-24 | -$500.00K 10-K · filed 2017-03-24 | |
| 2015-09-30 | -$125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$250.00K derived: sum of 2 quarters · filed 2016-11-10 | -$375.00K 10-Q · filed 2016-11-10 | -$500.00K derived: sum of 4 quarters · filed 2016-11-10 | |
| 2015-06-30 | -$125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$250.00K 10-Q · filed 2016-08-15 | -$375.00K derived: sum of 3 quarters · filed 2016-08-15 | -$500.00K derived: sum of 4 quarters · filed 2016-08-15 | |
| 2015-03-31 | -$125.00K 10-Q · filed 2016-05-16 | -$250.00K derived: sum of 2 quarters · filed 2016-05-16 | -$375.00K derived: sum of 3 quarters · filed 2016-05-16 | -$500.00K derived: sum of 4 quarters · filed 2016-05-16 | |
| 2014-12-31 | -$125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$250.00K derived: sum of 2 quarters · filed 2016-03-30 | -$375.00K derived: sum of 3 quarters · filed 2016-03-30 | -$500.00K 10-K · filed 2016-03-30 | |
| 2014-09-30 | -$125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$250.00K derived: sum of 2 quarters · filed 2015-11-05 | -$375.00K 10-Q · filed 2015-11-05 | -$500.00K derived: sum of 4 quarters · filed 2016-03-30 | |
| 2014-06-30 | -$125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$250.00K 10-Q · filed 2015-08-10 | -$375.00K derived: sum of 3 quarters · filed 2016-03-30 | -$500.00K derived: sum of 4 quarters · filed 2016-03-30 | |
| 2014-03-31 | -$125.00K 10-Q · filed 2015-05-11 | -$250.00K derived: sum of 2 quarters · filed 2016-03-30 | -$375.00K derived: sum of 3 quarters · filed 2016-03-30 | -$500.00K derived: sum of 4 quarters · filed 2016-03-30 | |
| 2013-12-31 | -$125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$250.00K derived: sum of 2 quarters · filed 2016-03-30 | -$375.00K derived: sum of 3 quarters · filed 2016-03-30 | -$500.00K 10-K · filed 2016-03-30 | |
| 2013-09-30 | -$125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$250.00K derived: sum of 2 quarters · filed 2014-11-10 | -$375.00K 10-Q · filed 2014-11-10 | ||
| 2013-06-30 | -$125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$250.00K 10-Q · filed 2014-08-07 | |||
| 2013-03-31 | -$125.00K 10-Q · filed 2014-05-08 | $4.88M 10-Q · filed 2013-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |